Henry Schein In (HSIC): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report


Henry Schein posted a solid third quarter with adjusted EPS of $1.34 in the third-quarter of 2014 increased 9.8% year over year and also beat the Zacks Consensus Estimate by 2.3%. Revenues rose 11.7% to $2.62 billion, edging past the Zacks Consensus Estimate by 2.54%. Animal Health continued to perform well while the core dental business picked up. The recent strategic acquisitions are expected to add value to the business. With the animal health market growing at a rapid pace and showcasing favorable trends, we are confident about further sales improvement. Henry Schein is currently investing in growth opportunities for new product launch, improve operating margin and develop new technology solutions that will improve the customer experience and elevate Henry Schein's position in the marketplace. We upgrade the stock to Outperform.


Headquartered in Melville, NY, Henry Schein Inc. (HSIC) is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Presently, Henry Schein operates in 25 countries.

At the end of 2012, the company served a vast distribution network worldwide with a selection of over 96,000 branded products. Additionally, Henry Schein offers other value-added services such as practice management software, e-commerce solutions and an array of financial services.

Henry Schein's four businesses Dental, Animal Health, Medical and Technology and Value-Added Services serve millions of customers worldwide. In 2013, the company recorded global net revenue of $9.56 billion, with annualized growth of 6.9%.

Source: Company

Henry Schein In (HSIC): Read the Full Research Report
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

HENRY SCHEIN IN (HSIC): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

This article appears in: Investing , Stocks

Referenced Stocks: HSIC



More from Zacks.com:

Related Videos



Most Active by Volume

  • $31.7466 ▼ 13.12%
  • $18.115 ▲ 1.31%
  • $26.245 ▲ 0.29%
  • $35.66 ▲ 0.88%
  • $15.085 ▲ 2.76%
  • $20.185 ▲ 2.20%
  • $34.7285 ▲ 1.16%
  • $6.99 ▲ 6.07%
As of 7/29/2015, 12:14 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by BankRate.com